Cart
sales@molnova.com
PF-06882961 Tris
CAS No. 2230198-03-3
PF-06882961 Tris( UNII-2HJV78O0SS )
Catalog No. M24014 CAS No. 2230198-03-3
PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 287 | In Stock |
|
| 10MG | 430 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 50MG | 977 | In Stock |
|
| 100MG | 1321 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2632 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-06882961 Tris
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
-
DescriptionPF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
-
In Vitro——
-
In Vivo——
-
SynonymsUNII-2HJV78O0SS
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGLP-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230198-03-3
-
Formula Weight676.7
-
Molecular FormulaC35H41FN6O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F.C(C(CO)(CO)N)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Méndez M, Matter H, Defossa E, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2020;63(5):2292-2307. doi:10.1021/acs.jmedchem.9b01071
molnova catalog
related products
-
PF-06882961
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
-
V-0219
V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.
-
LGD-6972
LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist.
